Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. The information contained herein is for informational purposes only. Nothing in this article should be ...

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Analysis: Blade Air Mobility, Inc. (BLDE) - BLDE currently holds a Momentum Style Score of A, indicating strong momentum characteristics [3] - The company has a Zacks Rank of 2 (Buy), suggesting it is positioned for potential outperformance in the market [4] - Over the past week, BLDE shares increased by 3.25%, while the Zacks Technology Services industry remained flat [6] - In a longer timeframe, BLDE's shares have risen by 26.85% over the past quarter and 18.87% over the last year, outperforming the S&P 500's gains of 3.59% and 14.21%, respectively [7] - The average 20-day trading volume for BLDE is 613,644 shares, indicating a bullish sentiment as the stock is rising with above-average volume [8] Earnings Outlook - In the last two months, three earnings estimates for BLDE have been revised upwards, while none have been lowered, improving the consensus estimate from -$0.17 to -$0.10 [10] - For the next fiscal year, two estimates have increased, and one has decreased, reflecting a generally positive outlook [10] Conclusion - Considering the strong momentum indicators and positive earnings revisions, BLDE is recommended as a 2 (Buy) stock with a Momentum Score of A, making it a potential candidate for near-term investment [12]

Core Insights - Blade Air Mobility participated in the first passenger-carrying flight of an electric aircraft in the U.S., marking a significant milestone in all-electric aviation within commercial airspace [1][2] - The flight utilized BETA Technologies' ALIA CTOL aircraft, which is designed for safe, efficient, and sustainable transport [2][3] - Blade's asset-light model and proprietary terminal infrastructure position the company to lead the transition to quiet, emission-free aircraft [3][4] Company Overview - Blade Air Mobility provides air transportation and logistics services, including organ transport for hospitals and passenger services primarily in the Northeast U.S. and Southern Europe [4] - The company aims to facilitate a seamless transition from traditional aircraft to Electric Vertical Aircraft (EVA or eVTOL), promoting lower-cost, quiet, and emission-free air mobility [4] Industry Context - The successful demonstration flight underscores the feasibility of electric aviation in metropolitan environments and highlights the potential for reducing congestion and emissions [3][8] - BETA Technologies is focused on producing next-generation electric aircraft and developing the necessary infrastructure for reliable charging across the U.S. [6]

Blade Air Mobility (BLDE) FY Conference Summary Company Overview - Blade Air Mobility operates in the short-distance aviation market, primarily focusing on helicopter services and transitioning to electric vertical takeoff and landing (eVTOL) aircraft as they become available [3][4] - The company has been operational for approximately ten years and has established a significant presence in the Northeast United States and Southern Europe [3][6] Core Business Segments Medical Transportation - Blade is the largest air transporter of human organs in the United States, with the medical segment accounting for about 60% of its business [7] - The medical business is highly profitable, with adjusted EBITDA expected to reach approximately $6 million for the passenger side, with additional growth anticipated [8][9] - The company is moving from low teens to high teens in profit margins for the medical side, while the passenger side is targeting high single-digit margins [12] Passenger Transportation - Blade's passenger business operates in a competitive landscape, particularly in the Northeast United States, where it has no direct competition [20] - The pricing model includes a subscription service that allows customers to fly for as low as $95, with an average checkout exceeding $300 [30][31] - The passenger business is characterized by seasonality, but Blade's asset-light model allows for flexible capacity management [13][15] Growth Opportunities eVTOL Transition - Blade is preparing for the integration of eVTOL aircraft, with expected deployment timelines in the Middle East by late 2025 and in the Northeast by late 2027 or 2028 [34][35] - The transition to eVTOL is anticipated to unlock significant growth due to quieter operations and increased landing zone availability [38][42] Medical Market Expansion - The medical market is experiencing high single-digit growth, driven by factors such as regulatory changes and advancements in perfusion technology [44] - Blade is expanding its service offerings, including ground transportation and clinical matching functions for organ transplants [46] Competitive Advantages - Blade's brand recognition and customer experience are key competitive advantages, with a focus on providing a seamless and enjoyable travel experience [47][50] - The company has developed a robust technology stack that enhances operational efficiency and customer engagement [51][52] Financial Position - Blade reported a clean balance sheet with approximately $120 million in cash and no debt, positioning the company well for future growth [11] - The company has achieved profitability ahead of schedule, with strong financial performance across both medical and passenger segments [10][54] Conclusion - Blade Air Mobility is well-positioned for future growth with a strong focus on both its medical and passenger transportation segments, leveraging its brand, technology, and operational efficiencies to capitalize on emerging opportunities in the aviation market [55][56]

Company Overview - Blade Air Mobility, Inc. is a technology-powered air mobility platform that provides air transportation and logistics for hospitals across the United States, being one of the largest transporters of human organs for transplant [2] - The company offers helicopter and fixed-wing services primarily in the Northeast United States and Southern Europe, operating under an asset-light model with exclusive passenger terminal infrastructure and proprietary technologies [2] Upcoming Events - The CEO Rob Wiesenthal and CFO Will Heyburn will present at the Jefferies eVTOL / AAM Summit on May 28, 2025, at 10:40 am ET, with a webcast available for investors [1] Business Model and Technology - Blade's model is designed to facilitate a seamless transition from traditional helicopters and fixed-wing aircraft to Electric Vertical Aircraft (EVA or eVTOL), aiming for lower-cost air mobility that is both quiet and emission-free [2]

Blade Air Mobility (BLDE) Conference Summary Company Overview - Blade Air Mobility has been operational for eleven years, initially focusing on helicopter passenger transport in New York and expanding to European markets such as Monaco, Nice, Cannes, and Geneva [1][2] - The company aims to transition from helicopters to electric vertical takeoff and landing (eVTOL) aircraft, leveraging an asset-light model that allows for future aircraft swaps [2][4] Industry Dynamics - The transition to eVTOL is expected to occur soon, with potential commercialization timelines for manufacturers like Adobe and Archer projected for late 2025 to early 2026 in the Middle East and late 2027 to early 2028 in the U.S. [10][11] - Blade is well-positioned to capitalize on this transition due to its established infrastructure and technology stack, which includes heliports in key markets [12][14] Key Business Segments Passenger Transport - Blade has successfully penetrated the passenger market, offering competitive pricing that has attracted a significant customer base [11] - The company has broken through pricing barriers, offering a $95 annual airport pass for frequent flyers [11] Medical Transport - Blade is the largest air transporter of human organs in the U.S., with a business generating approximately $150 million, surpassing its passenger transport revenue [5][6][37] - The medical segment is expected to grow in double digits, with a target margin expansion from 15% to high teens due to increased control over owned jets [34][35] - Blade holds about 30-35% of the organ transport market, indicating significant growth potential [37] Technological Advancements - The company is exploring the integration of AI in operations, aiming for enhanced safety and efficiency in future eVTOL aircraft [21][22] - Blade does not manufacture its own aircraft but collaborates with established manufacturers like Bell and Airbus [23] Financial Performance - Blade is ahead of its profitability projections, with adjusted EBITDA expected to exceed $10 million in 2025, up from just over $1 million last year [43][45] - The company maintains a strong financial position with $120 million in cash and zero debt, focusing on strategic acquisitions in the medical sector [40][42] Strategic Initiatives - Blade is actively seeking acquisitions that can enhance its medical transport capabilities and leverage existing hospital relationships [40][42] - The company is involved in various high-profile events to increase brand recognition and attract new customers, such as the Ryder Cup and major music festivals [28][29] Conclusion - Blade Air Mobility is strategically positioned to lead the transition to eVTOL aircraft while maintaining a strong foothold in the medical transport sector, showcasing impressive financial growth and operational efficiency [43][45]

Company Overview - Blade Air Mobility, Inc. is a technology-powered air mobility platform that provides air transportation and logistics for hospitals across the United States, being one of the largest transporters of human organs for transplant [2] - The company offers helicopter and fixed-wing services primarily in the Northeast United States and Southern Europe, operating an asset-light model with exclusive passenger terminal infrastructure and proprietary technologies [2] Upcoming Events - Rob Wiesenthal, the CEO of Blade, will present at the Ladenburg Thalmann Technology Innovation Expo 25 on May 21, 2025, at 3:00 PM ET, with a webcast available for investors [1] Business Model and Technology - Blade's model is designed to facilitate a seamless transition from traditional helicopters and fixed-wing aircraft to Electric Vertical Aircraft (EVA or eVTOL), aiming for lower-cost air mobility that is both quiet and emission-free [2]

Investors might want to bet on Blade Air Mobility, Inc. (BLDE) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by th ...

Core Viewpoint - Blade Mobility Inc. has seen a significant stock increase of over 18% following the release of its first-quarter earnings, highlighting positive financial performance and growth potential in the air mobility sector [1][3]. Company Overview - Blade Mobility operates in the air transport sector, offering services through a fleet that includes helicopters, private jets, turboprops, and amphibious seaplanes. The business is divided into two main verticals: Medical Services (58% of revenue) and Passenger Services (42% of revenue) [2][3]. Financial Performance - The company reported revenue of $54.3 million, exceeding expectations of $49.3 million, marking a 10% increase. The earnings per share showed a loss of four cents, which was better than the anticipated loss of 11 cents. Notably, Blade achieved its first-ever EBITDA profit of $0.1 million in the passenger segment [3][4]. - Blade reaffirmed its full-year revenue guidance of $245 million to $265 million, indicating a potential 2% year-over-year gain, driven by reduced aircraft maintenance and ongoing cost-saving measures [4]. Market Position and Future Outlook - Blade Mobility went public via a SPAC in 2020 and, despite facing challenges in the past, has shown resilience with a stock recovery from its 52-week low. The recent earnings report has positioned the stock above its 200-day simple moving average, suggesting bullish momentum [5][7]. - The air mobility sector is expanding, with growing interest in eVTOLs. Blade's core business in organ transport provides a significant first-mover advantage, making it less vulnerable to competition from companies like Joby Aviation and Archer Aviation [8]. - Analysts project a 12-month stock price forecast of $6.25, representing an 80.64% upside from the current price of $3.46, with a consensus indicating a bullish sentiment towards the stock [9][10].

Blade Air Mobility (BLDE) FY Conference May 14, 2025 03:40 PM ET Speaker0 Okay. Good afternoon, and, welcome to, JPMorgan's fifty third annual, tech conference. My name is Bill Peterson, Clean Tech Analyst. And we're pleased to have the team from Blade here. We have Matt Schneider, the VP of Investor Relations and Strategic Finance. Matt, thanks for joining the conference. Speaker1 Bill, thanks for having me at conference. Speaker0 Maybe as an introduction, we just had earnings here recently. Maybe we can g ...